Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045029-02
Application #
2144279
Study Section
Nutrition Study Section (NTN)
Project Start
1995-05-15
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
East Carolina University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
MacLean, Paul S; Vadlamudi, Satyaprasad; MacDonald, Kenneth G et al. (2005) Suppression of hepatic cholesteryl ester transfer protein expression in obese humans with the development of type 2 diabetes mellitus. J Clin Endocrinol Metab 90:2250-8
MacLean, Paul S; Bower, Joseph F; Vadlamudi, Satyaprasad et al. (2003) Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. Arterioscler Thromb Vasc Biol 23:1412-5
Maclean, P S; Tanner, C J; Houmard, J A et al. (2001) Plasma cholesteryl ester transfer protein activity is not linked to insulin sensitivity. Metabolism 50:783-8
MacLean, P S; Bower, J F; Vadlamudi, S et al. (2000) Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans. Obes Res 8:62-70
MacLean, P S; Barakat, H A (2000) Insulin does not regulate the promoter of cholesteryl ester transfer protein (CETP) in HIRc/pCETP-CAT cells. Mol Cell Biochem 211:7-Jan
MacLean, P S; Vadlamudi, S; MacDonald, K G et al. (2000) Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women. Metabolism 49:285-92
Lilley, S H; Spivey, J M; Vadlamudi, S et al. (1998) Lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus. J Clin Pharmacol 38:1107-15
Vadlamudi, S; MacLean, P; Israel, R G et al. (1998) Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins. Metabolism 47:1222-6